Researchers combined electronic sensors with human islet cells to create living ‘cyborg’ organoids transmitting troves of ...
Wendy Novak, who lived with Type 1 diabetes from age 7, passed away in 2024 from complications related to the disease. She and her husband, former Yum! Brands CEO David Novak, established the Lift a ...
Implantable islet cells could control diabetes without insulin injections, surviving in the body for at least 3 months and producing enough insulin to control blood sugar levels. Most diabetes ...
A small device implanted just beneath the skin, roughly the size of a large postage stamp and weighing about two grams, kept diabetic mice and rats healthy for three months without a single dose of ...
Most diabetes patients must carefully monitor their blood sugar levels and inject insulin multiple times per day, to help keep their blood sugar from getting too high. As a possible alternative to ...
Since Eledon Pharmaceuticals Inc.’s Phase 2 kidney trial failed to meet its primary endpoint, sending shares down nearly 50%, the Irvine-based biotech company is making progress in its other areas of ...
In a 14-month follow-up, Sana Biotechnology has found that its investigational allogeneic cell therapy continued to produce insulin in one patient with Type 1 diabetes, with no safety concerns ...
A false-color microscopy image of cells. A transmission electron microscopy image shows pancreatic cells. Credit: Steve Gschmeissner/Science Source A proof-of-concept trial in a single patient has ...
Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with custom-engineered immune cells that protect them. The goal is to stop the immune system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results